Nu Skin Enterprises (NUS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for May 29, 2025, to vote on director elections, executive compensation, incentive plan, and auditor ratification.
Board recommends approval of all proposals, including the Amended and Restated 2024 Omnibus Incentive Plan and PricewaterhouseCoopers LLP as auditor.
Proxy materials and annual report are available online; shareholders can vote by mail, phone, or internet.
Voting matters and shareholder proposals
Shareholders will vote on electing nine directors, an advisory say-on-pay vote, approval of the incentive plan, and auditor ratification.
Board recommends voting for all director nominees and proposals.
Shareholder proposals for the 2026 meeting must be submitted by December 17, 2025.
Board of directors and corporate governance
Board consists of nine members, with 75% required to be independent; current board meets this standard.
Separate Chairman and CEO roles; Lead Independent Director position established.
Annual board and committee evaluations are conducted, with a third-party facilitator used in 2024.
Mandatory retirement age of 77 for directors joining after 2023.
Equity retention, hedging, and pledging policies in place for directors and executives.
Latest events from Nu Skin Enterprises
- Q2 revenue fell 17.1% year-over-year to $320.1M, with adjusted EPS at $0.20 and broad declines.NUS
Q2 2026 - Q1 2026 revenue fell 12% to $320.6M, with EPS at $0.04 and guidance maintained.NUS
Q1 2026 - Director elections, compensation, incentive plan, and auditor ratification set for May 2026.NUS
Proxy filing - Proxy covers director elections, executive pay, incentive plan, auditor ratification, and governance.NUS
Proxy filing - 2025 EPS rose 51% despite revenue declines; 2026 growth expected from new launches and India expansion.NUS
Q4 2025 - Prysm iO and digital-first expansion in emerging markets are set to drive growth and stability.NUS
28th Annual ICR Conference 2026 - Q3 revenue fell 13.8%–14% YOY to $430.1M; Rhyz segments grew over 20% amid core declines.NUS
Q3 2024 - Q2 revenue fell 12.2% to $439.1M, with Rhyz up 32% and a $118.3M net loss on restructuring.NUS
Q2 2024 - Q4 revenue and EPS beat guidance but fell year-over-year; 2025 outlook remains cautious.NUS
Q4 2024